Moclobemide: Antidepressant Drug Profile

What is Moclobemide?

Moclobemide is an antidepressant medication that belongs to a class of drugs called reversible inhibitors of monoamine oxidase A (RIMA). It is primarily used to treat major depressive disorder and social anxiety disorder. Unlike older monoamine oxidase inhibitors, moclobemide has a more favorable safety profile and fewer dietary restrictions.

Uses

• Major depressive disorder: Primary indication for treating moderate to severe depression, particularly when other antidepressants have been ineffective
• Social anxiety disorder: Helps reduce symptoms of social phobia and performance anxiety
• Atypical depression: May be particularly effective for depression with symptoms like increased appetite, hypersomnia, and mood reactivity
• Treatment-resistant depression: Used as an alternative when first-line antidepressants like SSRIs or SNRIs have failed
• Seasonal affective disorder: Sometimes prescribed for winter depression when light therapy is insufficient

How it works

Moclobemide works by selectively and reversibly blocking monoamine oxidase A, an enzyme that breaks down neurotransmitters like serotonin, norepinephrine, and dopamine in the brain. By preventing the breakdown of these mood-regulating chemicals, moclobemide increases their availability in brain synapses. This enhanced neurotransmitter activity helps improve mood, reduce anxiety, and alleviate depressive symptoms.

Side effects

Common side effects:

• Nausea and digestive upset
• Headache
• Dizziness or lightheadedness
• Insomnia or sleep disturbances
• Dry mouth
• Restlessness or agitation
• Constipation
• Blurred vision

Serious side effects requiring immediate medical attention:

Submit Your Paper

• Severe hypertensive crisis (extremely high blood pressure)
• Serotonin syndrome symptoms (confusion, rapid heart rate, high fever, muscle rigidity)
• Severe allergic reactions with rash, swelling, or difficulty breathing
• Increased suicidal thoughts, especially in young adults under 25
• Severe liver problems (yellowing of skin or eyes, dark urine)

Warnings and precautions

• Pregnancy and breastfeeding: Should be used only when benefits outweigh risks; moclobemide passes into breast milk and may affect nursing infants
• Liver disease: Patients with severe liver impairment should avoid moclobemide or use reduced doses under close medical supervision
• Bipolar disorder: May trigger manic episodes in patients with undiagnosed bipolar disorder; mood should be carefully monitored
• Suicide risk: Like all antidepressants, may initially increase suicidal thoughts, particularly in patients under 25 years old
• Surgery: Should be discontinued at least one week before elective surgery due to potential interactions with anesthetic agents

Interactions

• SSRIs and SNRIs: Concurrent use can cause dangerous serotonin syndrome; requires washout periods between medications
• Tramadol and meperidine: Increased risk of serotonin syndrome and respiratory depression
• Sympathomimetics: Decongestants and stimulants may cause dangerous blood pressure elevation
• Tyramine-rich foods: Large amounts of aged cheese, cured meats, or fermented foods may cause hypertensive reactions, though risk is lower than with traditional MAOIs
• Cimetidine: Increases moclobemide blood levels, potentially requiring dose adjustment
• Dextromethorphan: Found in cough medicines, may interact to cause serotonin syndrome
• Triptans: Migraine medications may interact to cause serotonin syndrome
• St. John’s Wort: Herbal supplement increases serotonin syndrome risk

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosing for depression starts at 150 mg taken twice daily after meals, with the total daily dose ranging from 300-600 mg divided into two doses. For social anxiety disorder, the usual dose is 300-600 mg daily in divided doses. Doses should be taken after meals to reduce gastrointestinal side effects and improve absorption. The maximum recommended daily dose is typically 600 mg. Elderly patients or those with liver impairment may require lower starting doses. Dosage adjustments should always be made gradually under medical supervision, and individual patient response determines the optimal therapeutic dose.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).